
Vanguard LifeStrategy Growth Fund
VASGX
Updated: 24/09/2026, 00:40:22
This fund belongs to the Vanguard LifeStrategy series, a collection of broadly diversified, low-cost options that utilize an all-index, static asset allocation strategy, potentially serving as a complete portfolio. Each of the four funds in the series caters to different risk profiles. The Growth Fund specifically targets capital appreciation with some current income. Its portfolio is structured with 80% allocated to equities, which includes international stocks, and 20% to fixed income, also incorporating international bonds. Investors should be mindful of inherent risks such as stock market volatility, currency fluctuations, and country-specific issues, in addition to the risks associated with its underlying holdings. This fund is well-suited for individuals with a long-term investment horizon who aim for principal growth and are comfortable with market ups and downs. Please note that effective May 12, 2026, the fund's name will transition to the Vanguard LifeStrategy 80/20 Fund, though its investment objective, strategies, and policies will not change.
No summaries found.
- Share price
- $55.88
- Market cap
- $27.37B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- N/A
- Employees
- N/A
- IPO date
- 30/09/1994
- Beta
- 1.11
- Last dividend
- $0.00
- Day range
- $55.88 – $56.45
- 52-week range
- $48.92 – $56.83
- 1-day performance
- -1.01%
- 1-year performance
- 14.23%
- Current drawdown (1Y)
- -1.67%
- CIK
- 0000736054
- CUSIP
- 921909503
- ISIN
- US9219095034
- Created
- 07/12/2025, 14:55:43
- Last update
- 24/09/2026, 00:40:22
Track Vanguard LifeStrategy Growth Fund with an AI analyst
See which prediction-market events move VASGX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.